Fucomannogalactan and glucan from mushroom Amanita muscaria: Structure and inflammatory pain inhibition  by Ruthes, Andrea Caroline et al.
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a  b  s  t  r  a  c  t
A  fucomannogalactan  (FMG-Am)  and  a (1  → 3),  (1 →  6)-linked  -d-glucan  (GLC-Am)  were  isolated  from
Amanita  muscaria  fruiting  bodies.  These  compounds’  structures  were  determined  using mono-  and  bi-
dimensional  NMR  spectroscopy,  methylation  analysis,  and  controlled  Smith  degradation.  FMG-Am  was
shown  to be a  heterogalactan  formed  by  a (1 →  6)-linked  -d-galactopyranosyl  main  chain  partially  sub-
stituted  at O-2  mainly  by  -l-fucopyranose  and  a minor  proportion  of  -d-mannopyranose  non-reducingeywords:
manita muscaria
ucomannogalactan
1 → 3), (1 → 6) -d-Glucan
nti-inﬂammatory
end  units.  GLC-Am  was  identiﬁed  as a  (1 →  3)-linked  -d-glucan  partially  substituted  at O-6  by  mono-
and  a  few  oligosaccharide  side  chains,  which  was  conﬁrmed  after  controlled  Smith  degradation.  Both
the  homo-  and  heteropolysaccharide  were  evaluated  for their  anti-inﬂammatory  and  antinociceptive
potential,  and  they  produced  potent  inhibition  of  inﬂammatory  pain,  speciﬁcally,  91  ±  8%  (30  mg  kg−1)
and  88  ± 7%  (10  mg  kg−1), respectively.ain
. Introduction
Amanita muscaria (L.:Fr.) Person, commonly known as the ﬂy
garic mushroom, is a native species throughout the temperate
nd boreal regions of the northern hemisphere. However, because
his mushroom grows only in symbiosis with birch and/or pine
Pinus spp.) trees, it has been unintentionally introduced to many
ountries in the southern hemisphere.
Known as a toxic mushroom, A. muscaria contains muscarine,
uscinol and ibotenic acid, in addition to muscazone, which are
esponsible for its psychoactive effects. Although the toxins in A.
uscaria are water soluble, its consumption as a food has never
een widespread. Nevertheless, the consumption of detoxiﬁed A.
uscaria has been practiced in some localities in Europe and North
merica as sauce for steak (Coville, 1898) and in parts of Japan,
uch as in the Hokkaido area (Kiho, Katsuragawa, Nagai, & Ukai,
992). The assumed toxic characteristics of A. muscaria may  be
erived from investigations focused on the psychoactive com-
ounds present in its fruiting bodies.
∗ Corresponding author. Tel.: +55 41 3361 1655; fax: +55 41 3266 2042.
E-mail address: iacomini@ufpr.br (M.  Iacomini).
144-8617/$ – see front matter ©  2013 Elsevier Ltd. All rights reserved.
ttp://dx.doi.org/10.1016/j.carbpol.2013.06.061© 2013 Elsevier Ltd. All rights reserved.
Although it is well-known that many medicinal and therapeutic
properties are attributed to polysaccharides derived from mush-
rooms, little is known regarding A. muscaria polymers.
Among polysaccharides, glucans are the most abundant and
widely distributed carbohydrates in the fungal cell wall, and their
biological activities are thought to result from the presence of -d-
glucans, often of the (1 → 3) linkage type (Kulicke, Lettau, & Heiko,
1997; Willment, Gordon, & Brown, 2001). Such polymers are con-
sidered the most interesting functional components in mushrooms
(Manzi & Pizzoferrato, 2000). Consequently, there is great interest
in these molecules, especially in their roles as biological response
modiﬁers (Gonzaga, Ricardo, Heatly, & Soares, 2005; Lavi, Friesem,
Geresh, Hadar, & Schwartz, 2006; Smith, Rowan, & Sullivan, 2002).
Conversely, heterogalactans, especially those that contains
fucose, have been reported in basidiomycetes and exhibit enhanced
biological activities (Cho, Koshino, Yu, & Yoo, 1998; Lu, Cheng,
Lin, & Chang, 2010; Mukumoto & Yamaguchi, 1977). Most of
these heterogalactans obtained from mushrooms, such as Agari-
cus brasiliensis and Agaricus bisporus var. hortensis (Komura et al.,
2010), A. bisporus and Lactarius rufus (Ruthes, Rattmann, Carbonero,
Gorin, & Iacomini, 2012; Ruthes et al., 2013a), Flammulina velu-
tipes (Mukumoto & Yamaguchi, 1977; Smiderle et al., 2006),
Fomitella fraxinea (Cho et al., 1998), Fomitopsis pinicola (Usui,
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osokawa, Mizuno, Suzuki, & Megur, 1981), Ganoderma applana-
um (Usui, Iwasaki, & Mizuno, 1981), Laetiporus sulphureus (Alquini
t al., 2004) and Lentinus edodes (Carbonero et al., 2008; Shida,
aryu, & Matsuda, 1975), have a backbone of (1 → 6)-linked--
-galactopyranosyl residues, substituted at O-2 only by l-Fucp or
y l-Fucp in addition to d-Manp, d-Galp single units, or 3-O--d-
annopyranosyl--l-fucopyranosyl side chains.
Several physical and chemical properties, such as monosaccha-
ide composition, molecular weight, degree of branching, glycosidic
inkages and substituents, may  inﬂuence the biological activities of
olysaccharides (Bohn & BeMiller, 1995; Vetvicka & Yvin, 2004).
tructural characterization of polysaccharides has become impor-
ant for comparing chemical structure with biological properties.
In our recent studies, heterogalactans and branched (1 → 3),
1 → 6)-linked -d-glucans were puriﬁed and structurally charac-
erized from different mushroom species, and their antinociceptive
nd anti-inﬂammatory activities were evaluated and presented
otent inhibition of inﬂammatory pain (Ruthes et al., 2012, 2013a,
013b).
Consequently, the isolation, structural characterization and
valuation of the antinociceptive and anti-inﬂammatory poten-
ial of (1 → 3), (1 → 6)-linked -d-glucan and fucomannogalactan
rom A. muscaria fruiting bodies described in this study may  con-
ribute to a structure–activity relationship, as they have differences
n solubility, degrees of branching, molecular weight and sub-
tituents compared to similar polysaccharides that were previously
escribed.
. Materials and methods
.1. Biological material
Amanita muscaria (L.:Fr.) Person fruiting bodies were collected
n middle of May  2005 from the soil of a Pinus sp. reforestation
roject located in Mafra, Santa Catarina state, Brazil at latitude:
6◦13′S, longitude: 49◦50′W and an altitude of 826 m above sea
evel. They were identiﬁed by the mycologist André A. R. de Meijer,
leaned, vacuum dried, and subsequently ground to a powder.
.2. Extraction and puriﬁcation of polysaccharides
Extraction of crude polysaccharides obtained from A. muscaria
Am) and their puriﬁcation was carried out as described in the
owchart (Fig. 1).
Dried milled powder from A. muscaria fruiting bodies (30.0 g)
as submitted to successive cold (4 ◦C) and hot (∼98 ◦C) aque-
us and alkaline 2% aq. KOH extraction, the latter under reﬂux at
00 ◦C for 6 h (6×,  1 L) each. The extracted polysaccharides were
ecovered from the aqueous extracts by the addition of excess
tOH or after dialysis from HOAc-neutralized alkaline extracts,
esulting in fractions CW (cold water), HW (hot water) and K2
alkaline 2%), respectively. The crude fractions obtained from hot
queous (HW) and alkaline (K2) extractions were submitted to a
reeze–thawing process (Gorin & Iacomini, 1984), furnishing cold
ater-soluble (SHW and SK2) and -insoluble polysaccharide frac-
ions, which were separated by centrifugation (8000 rpm, 20 min,
◦C). The water-soluble fractions were treated with Fehling solu-
ion (Jones & Stoodley, 1965), and the soluble fractions (FSHW and
SK2) were isolated from the insoluble Cu2+ complexes (FPHW and
PK2) by centrifugation under the same conditions as described
bove. The respective fractions were each neutralized with HOAc,
ialyzed against tap water and deionized with mixed ion exchange
esins and later freeze dried.
FPHW fraction was further puriﬁed by closed dialysis through
 membrane with a 100 kDa Mw cut-off (Spectra/Por® Celluloseolymers 98 (2013) 761– 769
Ester), giving rise to a retained (R-FPHW) and an eluted (E-FPHW)
material (Fig. 1).
2.3. Monosaccharide composition
Each polysaccharide fraction (1 mg)  was  hydrolyzed with 2 M
TFA at 100 ◦C for 8 h, followed by evaporation. The resulting residue
was reduced with NaBH4 (1 mg)  and acetylated with Ac2O–pyridine
(1:1, v/v; 200 L) at 100 ◦C for 30 min  following the method of
Sassaki et al. (2008). The resulting alditol acetates were analyzed
by gas chromatography–mass spectrometry (GC–MS) using a Var-
ian model 3300 gas chromatograph linked to a Finnigan Ion-Trap,
Model 810-R12 mass spectrometer. A DB-225 capillary column
(30 m × 0.25 mm i.d.) held at 50 ◦C during injection and later pro-
grammed to 220 ◦C (constant temperature) at 40 ◦C min−1 was used
for qualitative and quantitative analysis of alditol acetates. The
alditol acetates were identiﬁed by their typical retention times and
electron impact proﬁles.
2.4. Determination of homogeneity and polymer molecular
weight (Mw)
The homogeneity and molecular weight (Mw) of water-soluble
puriﬁed polysaccharide fractions FMG  and GLC were determined
by high-performance steric exclusion chromatography (HPSEC)
using a refractive index (RI) detector. The eluent was 0.1 M NaNO3
containing 0.5 g L−1 NaN3. The solutions were ﬁltered through a
membrane with pores of 0.22-m diameter (Millipore). The spe-
ciﬁc refractive index increment (dn/dc) was determined using a
Waters 2410 detector. The samples were dissolved in the eluent
in ﬁve increasing concentrations ranging from 0.2 to 1.0 mg  mL−1
to determine the slope of the increment.
2.5. Methylation analysis
Per-O-methylation of puriﬁed FMG-Am and GLC-Am fractions
(10 mg each) was carried out using NaOH–Me2SO–MeI, a method
modiﬁed from Ciucanu and Kerek (1984) as described by Ruthes
et al. (2010). The per-O-methylated derivatives were hydrolyzed
with 45% formic acid (HCO2H, 1 mL)  for 15 h at 100 ◦C (Carbonero
et al., 2012), followed by NaBD4 reduction and acetylation as above
(Section 2.3) to give a mixture of partially O-methylated alditol
acetates that was  analyzed by GC–MS using a Varian model 4000
gas chromatograph equipped with DB-225 capillary columns. The
injector temperature was  maintained at 210 ◦C, with the oven
increasing from 50 ◦C (hold 2 min) to 90 ◦C (20 ◦C min−1, then held
for 1 min), 180 ◦C (5 ◦C min−1, then held for 2 min) and to 210 ◦C
(3 ◦C min−1 and held for 5 min). Helium was used as the carrier
gas at a ﬂow rate of 1.0 mL  min−1. Partially O-methylated alditol
acetates were identiﬁed from m/z by comparing their positive ions
with standards, with the results being expressed as a relative per-
centage of each component (Sassaki, Gorin, Souza, Czelusniak, &
Iacomini, 2005).
2.6. Controlled Smith degradation of ˇ-d-glucan
The puriﬁed glucan (GLC-Am; 100 mg)  was submitted to oxi-
dation with 0.05 M aqueous NaIO4 (15 mL)  at room temperature
for 72 h in the dark. Ethylene glycol was added to stop the reaction,
the solution was  dialyzed, and the resulting polyaldehydes were
reduced with NaBH4 for 24 h, neutralized with HOAc, dialyzed, and
concentrated (Goldstein, Hay, Lewis, & Smith, 2005). The residue
was partially hydrolyzed with TFA pH 2.0 (30 min at 100 ◦C) (Gorin,
Horitsu, & Spencer, 1965) followed by dialysis against tap water
using a membrane with a size exclusion of 2 kDa, and the solu-
tion containing the retained material was freeze-dried. An aliquot
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(Fig. 1. Scheme of extraction and puriﬁcation of heteroga
40 mg)  of the degraded fraction was submitted to 13C NMR  spec-
roscopy, and 10 mg  was submitted to methylation analysis.
.7. Nuclear magnetic resonance (NMR) spectroscopy
13C NMR  spectra were obtained using a 400 MHz Bruker model
RX Avance spectrometer incorporating Fourier transform. Anal-
ses were performed at 70 ◦C on samples dissolved in D2O or
e2SO-d6. Chemical shifts of water-soluble samples are expressed
n ı (ppm) relative to acetone at ı 30.20 and 2.22 for 13C and 1H
ignals, respectively, and at ı 39.70 (13C) and 2.40 (1H) for those
issolved in Me2SO-d6.
.8. Experimental animals
Experiments were conducted using Swiss mice of both sexes
25–35 g) provided from Universidade Federal de Santa Catarina
UFSC) facilities that were kept in an automatically controlled tem-
erature room (20 ± 2 ◦C) on a 12-h light–dark cycle (light on from
:00 h) with food and water freely available. Animals (male and
emale mice were homogeneously distributed among groups) were
cclimatized to the laboratory for at least 2 h before testing and
ere used only once for experiments. Protocols were approved by
he Institutional Ethics Committee of the Universidade Federal de
anta Catarina and were in accordance with current guidelines for
he care of laboratory animals and ethical guidelines for investi-
ation of experimental pain in conscious animals (Zimmermann,
983). The numbers of animals and intensities of noxious stimuli
sed were the minimum necessary to demonstrate consistent
ffects of the drug treatments.
.9. Nociception induced by intraplantar injection of formalin
Animals received 20 L of a 2.5% formalin solution (0.92%
ormaldehyde in saline), injected intraplantarly in the ventral sur-
ace of the right hind paw. Animals were observed from 0 to
 min  (early phase) and 15–30 min  (late phase). Mice were treated
ith different doses of the FMG-Am (1–10 mg  kg−1) and GLC-Am
1–30 mg  kg−1) by the intraperitoneal route 30 min  beforehand. (FMG-Am)  and -d-glucan (GLC-Am) from A. muscaria.
Control animals received a similar volume of saline solution
(10 mL  kg−1, i.p.) that was  used to dilute the FMG-Am and GLC-Am.
After the intraplantar injection of formalin, the animals were imme-
diately placed in a glass cylinder 20 cm in diameter. The time that
they spent licking the injected paw was recorded with a chronome-
ter and considered to be indicative of nociception.
2.10. Statistical analysis
The results are presented as the mean ± standard error of the
mean (SEM), except for the ID50 values (i.e., the dose of polysaccha-
ride necessary to reduce the nociceptive response by 50% relative
to the control value), which were reported as geometric means
accompanied by their respective 95% conﬁdence limits. The ID50
value was determined by nonlinear regression from individual
experiments using GraphPad software (San Diego, CA, USA). The
statistical signiﬁcance of differences between groups was detected
by ANOVA followed by Newman–Keuls’ test. P-values less than 0.05
(p < 0.05) were considered indicative of signiﬁcance.
3. Results and discussion
3.1. Structural characterization of heterogalactan
Fruiting bodies of A. muscaria were submitted to successive cold
and hot aqueous extraction (Fig. 1). Polysaccharides were recov-
ered from hot aqueous extracts by ethanol precipitation followed
by centrifugation and dialysis against tap water. The solution was
then freeze-dried to produce fraction HW (Fig. 1).
First, fractionation and puriﬁcation of HW was carried out by
a freeze-thawing procedure (Gorin & Iacomini, 1984), resulting in
the cold water-soluble fraction SHW (1.14 g, 3.8% yield).
Fraction SHW gave a heterogeneous HPSEC elution proﬁle;
therefore, it was puriﬁed by treatment with Fehling solution fol-
lowed by closed dialysis of fraction FPHW (1.02 g, 3.4% yield)
through a 100 kDa Mw cut-off membrane (Fig. 1). The retained frac-
tion (R-FPHW; 0.96 g, 3.2% yield) was homogeneous by HPSEC, and
had a Mw 25.5 × 103 g mol−1 (dn/dc 0.163 mL  g−1) (Fig. 2A). This
fraction contained fucose (22%), mannose (9%) and galactose (69%)
764 A.C. Ruthes et al. / Carbohydrate Polymers 98 (2013) 761– 769
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bFig. 2. Elution proﬁles of fractions FMG-Am (A) and GLC-Am (B) determ
s monossacharide components, suggesting the presence of a het-
rogalactan, and it was named FMG-Am.
Analysis by GC–MS of the partially O-methylated alditol acetates
f FMG-Am suggested the existence of a highly branched struc-
ure consistent with a fucomannogalactan due to the presence of
artially O-methylated derivatives 2,3,4-Me3-Fuc (21.6%), 2,3,4,6-
e4-Man (8.9%), 2,3,4-Me3-Gal (37.6%), and 3,4-Me2-Gal (31.9%)
Table 1).
NMR  analysis [13C- (Fig. 3A), DEPT (Fig. 3A′) and HSQC (Fig. 3B)]
ontributed to the elucidation of the fucomannogalactan (FMG-Am)
tructure because the coupling of protons of its units enable assign-
ents of their respective carbons using HSQC analysis (Fig. 3B). The
SQC spectrum of FMG-Am contained H-1 signals corresponding to
on-reducing end groups of d-Manp (ı 4.83) and l-Fucp (ı 5.11), as
ell as units of 6-O-(ı 5.02) and 2,6-di-O-substituted d-Galp (ı 5.17,
.16, and 5.08) (Table 2). The 13C NMR  spectrum (Fig. 3A) of FMG-
m shows an overlapping of signals relative to d-Manp and l-Fucp
on-reducing end units; the HSQC spectrum (Fig. 3B′) had signals
C-1/H-1) at ı 104.0/4.83 and 103.9/5.11 corresponding to d-Manp
nd l-Fucp units, respectively (Table 2).
As for the C-1 signals from the d-Manp and l-Fucp units, those
rom 2,6-di-O- (ı 101.0/5.16, 100.7/5.17 and 100.7/5.08), and 6-O-
ubstituted d-Galp residues (ı 100.3/5.02) could only be attributed
fter HSQC analysis (Fig. 3B′; Table 2) because the 13C NMR  spec-
rum of FMG-Am presents a superposition of signals at the anomeric
egion at ı 100.6. The glycosidic conﬁgurations were conﬁrmed by
alues of the coupling constants JC-1,H-1 found in 1H/13C coupled
MQC spectrum (Perlin & Casu, 1969). The non-reducing ends of
able 1
artially O-methylated alditol acetates formed on methylation analysis of the fucomanno
odies: linkage types.
Partially O-methylated alditol acetatesa Rtb % Area o
FMGd
2,3,4-Me3-Fuc 6.507 21.6 
2,3,4,6-Me4-Man 7.726 8.9 
2,3,4,6-Me4-Glc 7.985 – 
2,4,6-Me3-Glc 10.039 – 
2,3,4-Me3-Gal 10.737 37.6 
3,4-Me2-Gal 12.156 31.9 
2,4-Me2-Glc 14.627 – 
a GC–MS analysis on a DB-225 capillary column.
b Retention time (min).
c Based on derived O-methyalditol acetates.
d FMG-Am: fucomannogalactan isolated from A. muscaria.
e GLC-Am: – (1 → 3), (1 → 6)-linked -d-glucan isolated from A. muscaria.
f SM-GLC – -d-glucan product after controlled Smith degradation. by HPSEC using light scattering (—) and refractive index detectors ( ).
d-Manp have a -conﬁguration consistent with a value of 162.8 Hz.
The residues of d-Galp and l-Fucp had an -conﬁguration in agree-
ment with a 172.3 Hz coupling constant.
The 6-O-substituted signals of d-Galp units were present at ı
69.2, 69.4, 69.7, 69.8, and 70.1 in the 13C NMR  (Fig. 3A) and HSQC
spectra (Fig. 3B), which were conﬁrmed from the inverted signals
in its DEPT spectrum (Fig. 3A′).
The signals at ı 72.8/4.21, 75.4/3.67, 69.5/3.63, 78.6/3.41, and
63.5/3.96; 3.78 arose from C-2/H-2 to C-6/H-6 of the d-Manp
units, respectively, while those at ı 72.3/3.82, 71.3/3.84, 74.2/3.88,
72.2/4.16, and 18.1/1.27 were from similar C-2/H-2 to C-6/H-6 cor-
relations of l-Fucp residues (Table 2) (Carbonero et al., 2008).
According to the literature, the C-2 of d-Galp units O-substituted
by d-Manp could be assigned at ı 79.4. These d-Galp units also
had signals of C-1/H-1 at ı 101.0/5.16 and 100.7/5.17 (Carbonero
et al., 2008). The C-2 signal of d-Galp units O-substituted by l-Fucp
appeared at ı 80.3 and corresponds to d-Galp units with C-1/H-1 at
d 100.7/5.08 (Carbonero et al., 2008).
The results of the monosaccharide composition analyses,
methylation data, and NMR  analysis of FMG-Am show it to be a fuco-
mannogalactan containing a (1 → 6)-linked, -d-galactopyranosyl
main chain that is partially substituted at O-2  mainly by -l-
fucopyranose and in a minor proportion by -d-Mannopyranose
as non-reducing end units.
Polysaccharides resembling FMG-Am have been previously
identiﬁed in extracts of fruiting bodies of L. edodes (Carbonero et al.,
2008; Shida et al., 1975), where both l-fucose and d-mannose are
present exclusively as terminal residues in the heterogalactan, as
galactan (FMG-Am)  and -d-glucan (GLC-Am) obtained from A. muscaria fruiting
f fragmentsc Linkage type
GLCe SM-GLCf
– – Fucp-(1→
– – Manp-(1→
29.9 2.5 Glcp-(1→
40.3 95.3 3→)-Glcp-(1→
– – 6→)-Galp-(1→
– – 2,6→)-Galp-(1→
29.8 2.2 3,6→)-Glcp-(1→
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escribed in this study for A. muscaria. The difference observed is
elated to d-Manp and l-Fucp content as non-reducing end units;
n FMG  from A. muscaria, l-Fucp (21%) appears in greater amount
han d-Manp (2%), and in L. edodes fucomannogalactan, the inverse
s observed (d-Manp – 21% and l-Fucp – 11%) (Carbonero et al.,
008).
There have been several other reports dealing with the iso-
ation and characterization of heterogalactans of basidiomycetes.
ost of these compounds have a common structure consisting
f a backbone of (1 → 6)-linked, -d-galactopyranose residues,
ome of which are substituted at C-2 either by l-fucopyranose
r 3-O-mannopyranosyl-l-fucopyranosyl residues, such as those
escribed for Armillaria mellea (Bouveng, Fraser, & Lindberg, 1967;
raser & Lindberg, 1967), F. fraxinea (Cho et al., 1998; Cho, Yun,
oo, & Koshino, 2011), G. applanatum (Usui et al., 1981b), F. velu-
ipes (Mukumoto & Yamaguchi, 1977; Smiderle et al., 2006), L.
ulphureus (Alquini et al., 2004), Polyporus fomentarius (Björnal &
indberg, 1969), Polyporus giganteus (Bhavanandan, Bouveng, &
indberg, 1994), Polyporus pinicola (Fraser, Karacsonyi, & Lindberg,
able 2
H and 13C NMR  chemical shifts [expressed as ı (ppm)] of fractions FMG-Am, GLC-Am a
Units 1 2 
FMG-Am
-l-Fucp-(1→ 13C 103.9 72
1H 5.11 3
-d-Manp-(1→ 13C 104.0 72
1H 4.83 4
2,6→)--d-Galp-(1→ 13C 100.7/101.0 80
1H 5.17;5.08/5.16 3
6→)--d-Galp-(1→ 13C 100.3 71
1H 5.02 3
GLC-Am
-d-Glcp-(1→ 13C 103.0 73
1H 4.30 3
3→)--d-Glcp-(1→ 13C 102.9 72
1H 4.51 3
3,6→)--d-Glcp-(1→ 13C 102.6 72
1H 4.51 3
SM-GLC
3→)--d-Glcp-(1→ 13C 102.9 72
1H 4.43 3
Assignments are based on 13C, 1H, DEPT, COSY and HMQC analysis.) spectra of fucomannogalactan; FMG-Am was analyzed in D2O at 70 C (chemical
1967), and Polyporus squamosus (Bjorndal & Wagstrom, 1969).
Heterogalactans lacking d-Mannopyranose as end-units, known as
fucogalactans, have also been described for mushrooms in A. bis-
porus (Ruthes et al., 2012, 2013a), A. brasiliensis and A. bisporus var.
hortensis (Komura et al., 2010), Coprinus commatus (Fan et al., 2006),
Hericium erinaceus (Zhang et al., 2006), and L. rufus (Ruthes et al.,
2012).
In addition to presenting well-known chemical structures,
heterogalactans are also recognized for their relevant biological
activities (Carbonero et al., 2008; Fan et al., 2006; Komura et al.,
2010; Ruthes et al., 2012, 2013a).
3.2. Structural characterization of (1 → 3), (1 → 6) ˇ-d-glucan
For -d-glucan puriﬁcation, extract K2 was primarily submitted
to the freeze–thawing procedure (Gorin & Iacomini, 1984), result-
ing in the respective cold water-soluble fraction SK2 (750 mg,  2.5%),
which yielded a heterogeneous HPSEC elution proﬁle. Therefore,
the fraction was puriﬁed by treatment with Fehling solution. FSK2
nd SM-GLC from A. muscariaa.
3 4 5 6
a b
.3 71.3 74.2 72.2 18.1 –
.82 3.84 3.88 4.16 1.27 –
.8 75.4 69.5 78.6 63.5 63.5
.21 3.67 3.63 3.41 3.96 3.78
.3 71.1 71.2 71.7 69.7 69.7
.84 4.08 4.09 4.21 3.70 4.01
.1 72.4 72.4 71.7 69.4 69.4
.84 3.89 4.03 4.21 3.72 3.93
.4 76.0 70.3 75.0 60.9 60.9
.13 3.29 3.23 3.41 3.70 3.53
.8 85.5/85.0 68.3 75.7 60.9 60.9
.32 3.53 3.31 3.41 3.70 3.53
.8 84.8/84.7 68.3 75.7 68.8 68.8
.32 3.53 3.31 3.41 3.98 3.98
.8 86.1 68.4 76.3 60.9 60.9
.23 3.40 3.18 3.18 3.69 3.40
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(ig. 4. C NMR  spectrum of -d-glucan (A), with insert of DEPT-CH2 inversion (A );
roduct (C). Analysis were done in D2O (A and C) and Me2SO-d6 (B) at 70 ◦C (chemi
366 mg,  1.2%) proved to be homogeneous on HPSEC with a Mw
6.2 × 103 g mol−1 (dn/dc 0.148 mL  g−1) (Fig. 2B).
Fraction FSK2 contained only glucose as its monosaccharide
omponent (GC–MS), and it was named GLC-Am. Analysis by
C–MS of its partially O-methylated alditol acetates suggested the
xistence of a branched (1 → 3), (1 → 6)-linked -d-glucan due to
he presence of partially O-methylated derivatives 2,3,4,6-Me4-Glc,
,4,6-Me3-Glc, and 2,4-Me2-Glc, determined in a molar ratio of
1:1.4:1 (Table 1).
Fraction GLC-Am was examined using NMR  spectroscopy, and
ignals were assigned using 1D (1H, 13C, and DEPT) and 2D NMR
pectra (1H (obs.) 13C HMQC and COSY). All of the signals were com-
ared to literature values for similar polysaccharides (Carbonero
t al., 2006; Chauveau, Talaga, Wieruszeski, Strecker, & Chavant,
996; Ruthes et al., 2013b; Santos-Neves et al., 2008; Smiderle et al.,
006, 2008; Tabata, Ito, & Kojima, 1981; Yoshioka, Tabeta, Saito,
ehara, & Fukuoka, 1985).
13C NMR  (Fig. 4A), and 1H (obs.) 13C HMQC spectra (Fig. 4B) of -
-glucan contained three distinct signals in the anomeric region at
 103.0/4.30, 102.9/4.51 and 102.7/4.56 (Table 2), corresponding to
he non-reducing end, and 3-O- and 3,6-di-O-substituted residues,
espectively. The -conﬁguration was conﬁrmed by low-frequency
f H-1 (ı 4.56, 4.51, 4.30 and 4.21) and high-frequency C-1 signals
ı 103.1, 102.9 and 102.7) (Fig. 4A and B) (Hall & Johnson, 1969). The
lycosidic linkages of the glucan were shown by the presence of 3-
-substituted signals at ı 85.4, 85.1 and 84.9 for GLC (Fig. 4A). The
-6 substitution was conﬁrmed from the respective reversed peak
n the DEPT spectrum (Fig. 4A′), and it also appeared as doublet in
MQC at ı 68.8; 3.98/3.66 (Fig. 4B).
The backbone structure of the isolated glucan was  character-
zed by controlled Smith degradation, and its remaining product
SM-GLC) was analyzed by 13C NMR  (Fig. 4C) spectroscopy and.)/ C HMQC spectrum of GLC-Am (B), and C NMR  spectrum of its Smith-degraded
ifts are expressed in ı ppm).
1H (obs.) 13C HMQC (data not shown). It can be assumed that
the GLC-Am fraction has a linear main-chain formed by (1 → 3)-
linked -d-glucan due to the presence of typical C/H signals
shown in Table 2, at ı 102.9/4.43 (C-1/H-1); 86.1/3.40 (C-3/H-3);
76.3/3.18 (C-5/H-5); 72.8/3.23 (C-2/H-2); 68.4/3.18 (C-4/H-4), and
60.9/3.69;3.40 (C-6/H-6a;b) (Gorin, 1981). In the degraded fraction
of the soluble glucan (SM-GLC), low-intensity signals from O-6
substitution were still present (Fig. 4C), indicating that this glucan
is mostly substituted at O-6 by single-units of -d-Glcp and a minor
proportion by side chains of 3-O-substituted -d-glucopyranosyl
oligosaccharides.
The product of controlled Smith degradation was methylated,
and the alditol GC–MS analysis conﬁrms the NMR data. The SM-
GLC fraction presented not only substitutions by non-reducing
end units but also substitution by (1 → 3)-linked -d-Glcp side
chains (Table 1) (Carbonero et al., 2006; Chauveau et al., 1996;
Ruthes et al., 2013b; Santos-Neves et al., 2008; Smiderle et al., 2008;
Yoshioka et al., 1985).
In conclusion, the results of the monosaccharide composi-
tion, methylation data, NMR  spectroscopic analysis, and controlled
Smith degradation of the studied fraction GLC-Am indicated the
presence of a -d-glucan with a main-chain that is (1 → 3)-linked,
partially substituted at O-6 mostly by non-reducing end units of
-d-Glcp as side-chains, and a minor proportion 3-O-substituted
by -d-glucopyranosyl oligosaccharides.
GLC-Am appears to be similar to the soluble glucan puriﬁed
from L. rufus fruiting bodies (Ruthes et al., 2013b). The structure we
described for A. muscaria is less branched than that described for L.
rufus but more branched than the previous -d-glucan described
for A. muscaria, where branches were primarily single (1 → 6)-
linked, two for every seven residues in the (1 → 3)-linked main
chain (Kiho et al., 1992).
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Fig. 5. Effects of intraperitoneally administered FMG-Am and GLC-Am on formalin-induced nociception (early phase, panels A and C; and late phase, panels B and D) in
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wice.  Each column represents the mean 4–6 animals ± S.E.M. Control values (C) indic
enote the signiﬁcance levels when compared with the control group; *p < 0.05, **p
.3. Effects of FMG-Am and ˇGLC-Am on nociception induced by
ntraplantar injection of formalin
Pain remains an important health problem; in certain patients,
t could be controlled by better application of existing thera-
ies, but other conditions lack effective treatments. Recent studies
ave been demonstrated that mushroom extracts and isolated
olysaccharides from their fruiting bodies have presented anti-
nﬂammatory and antinociceptive effects.
In this study, we evaluated the possible anti-inﬂammatory and
ntinociceptive effects of a heterogalactan (FMG-Am)  and a -d-
lucan (GLC-Am) isolated from A. muscaria in the formalin model,
 widely used model of persistent pain that is a mainstay for the
evelopment of novel agents for the treatment of postoperative
ain (Shields, Cavanaugh, Lee, Anderson, & Basbaum, 2010).
It is well-established that the nociception promoted by the
njection of formalin consists of two phases: neurogenic pain (early
hase), which is provoked by direct activation of nociceptors, and
nﬂammatory pain (late phase) that is mediated by a combination of
eripheral input and spinal cord sensitization, mainly due to release
f pro-inﬂammatory mediators (Hunskaar & Hole, 1987; Tjølsen,
erge, Hunskaar, Rosland, & Hole, 1992).
Our results demonstrated that intraperitoneal administration of
GLC-Am reduced the neurogenic pain (early phase) with an ID50
alue of 16.54 (8.64– 31.65) mg  kg−1 and inhibition of 64 ± 3% at
ose of 30 mg  kg−1 (Fig. 5A), while FMG-Am did not produce an
nhibitory effect on the early phase at all tested doses (Fig. 5C).
owever, GLC-Am and FMG-Am were more effective against the
nﬂammatory pain (late phase) of formalin-induced nociception
ith ID50 values of 2.41 (1.13–5.14) and 3.41 (2.10–5.52) mg  kg−1,e animals injected with saline or vehicle (saline plus 5% Tween 80) and the asterisks
 and ***p < 0.001 (One-way ANOVA followed by the Newman–Keuls test).
respectively, and inhibition of 91 ± 8% at dose of 30 mg  kg−1 of
GLC-Am and 88 ± 7% at a dose of 10 mg  kg−1 of FMG-Am (Figs. 5B
and D).
Interestingly, it was demonstrated that a similar fucomanno-
galactan isolated from L. edodes also showed antinociceptive and
anti-inﬂammatory properties using the model of abdominal con-
strictions induced by acetic acid (Carbonero et al., 2008), which,
additionally, involves endogenous inﬂammatory mediators. This
polymer (100 mg  kg−1) inhibited the nociceptive response, leuko-
cyte inﬁltration and peritoneal capillary permeability by 97, 100
and 76%, respectively (Carbonero et al., 2008).
The effects on nociception induced by intraplantar injec-
tion of formalin of A. muscaria FMG-Am (2.2 × 104 g mol−1) were
compared with those observed for A. bisporus fucogalactan
(37.1 × 104 g mol−1) using the same model (Ruthes et al., 2013a).
FMG-Am was  capable of inhibiting the inﬂammatory pain at a lower
dose (10 mg  kg−1; 88 ± 7%), while the fucogalactan presented sim-
ilar inhibition (82 ± 9%) but at a higher dose (100 mg kg−1) (Ruthes
et al., 2013a). The potency of the inhibitory effect was also dif-
ferent when comparing both heterogalactans. FMG-Am proved to
be more potent [ID50 3.41 (2.10–5.52) mg kg−1] than the fuco-
galactan from A. bisporus [ID50 36.0 (25.0–50.3) mg  kg−1]. Both are
heterogalactans with the same main structure, (1 → 6)-linked -
d-galactopyranosyl units, partially substituted at O-2 mainly by
-l-fucopyranose. However, while FMG-Am also presents O-2 sub-
stitution by d-Manp units, A. bisporus fucogalactan does not but
presents 3-O-Me-d-Galp units at the main chain (Ruthes et al.,
2013a). These differences in structures and molecular weight could
be responsible for the differences observed, especially regarding
the potency of inhibitory effects.
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Regarding the -d-glucan, the soluble (1 → 3), (1 → 6) -
-glucan previously isolated from L. rufus inhibited the noci-
eptive response induced by formalin with an ID50 value of
.35 (1.48–3.75) mg  kg−1 for the late phase (Ruthes et al.,
013b). This polysaccharide exhibits a higher molecular weight
11.3 × 104 g mol−1) and degree of branching than the (1 → 3),
1 → 6) -d-glucan (GLC-Am) (1.6 × 104 g mol−1) isolated from A.
uscaria at the same phase [ID50 2.41 (1.13–5.14) mg  kg−1]. How-
ver, their inhibitory effects observed in the late phase of the
ormalin test are not signiﬁcantly different, and the potency based
n their ID50 values is similar. Conversely, the inhibition observed
n neurogenic pain was more pronounced for GLC-Am (64 ± 3%),
hen compared with L. rufus -d-glucan (36 ± 8%) (Ruthes et al.,
013b).
When comparing the GLC-Am inhibitory effect against inﬂam-
atory pain (91 ± 8%) with the almost linear product (86 ± 9%)
roduced after controlled Smith degradation of the soluble (1 → 3),
1 → 6)-linked -d-glucan from L. rufus (Ruthes et al., 2013b), we
bserved that the degree of branching followed by the resultant dif-
erence in solubility have great importance for the antinociceptive
ffect of -d-glucans in response to inﬂammatory pain.
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